Louisiana pharmacy CEO pleads guilty to $50M reimbursement fraud

Central Rexall Drugs was paid more than $50 million in compensations from drug store benefits managers from 2015 to 2016, according to regional authorities. Ms. Taff, who will be sentenced Dec. 1, got more than $1.5 million from the scheme.

More short articles on pharmacy: Merck bets on one-shot vaccineUS indications $1.5 B offer for 100 million doses of Modernas coronavirus vaccine candidateVirginia drug store school files suit versus accreditation agency, calls procedure bizarrely inconsistent and Kafkaesque.

Ms. Taff and her co-conspirators hired public staff members in New Jersey to get expensive specialized prescriptions they had actually not been prescribed.

Ms. Taff pleaded guilty to conspiracy to dedicate health care fraud and agreed to pay back more than $1.5 million. She might face up to 10 years in prison.

Hayley Taff, CEO of Hammond, La.-based pharmacy Central Rexall Drugs, pleaded guilty Aug. 12 to playing a crucial function in a scheme that amassed more than $50 million in incorrect repayments.

Katie Adams –
Thursday, August 13th, 2020

Recruiters informed the clients which medications to get based on how much repayment the drug store would get from insurance provider for the drugs, not since the patients needed them. The drugs covered within these New Jersey employees insurance coverage plans consisted of costly pain, antifungal, scar and libido medications with reimbursements that frequently ran as high as thousands of dollars monthly, WNBC reported.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this material? View our policies by clicking here.

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.